Latest Strategic Investments News

Foresta Group Holdings has updated its share registry provider, extended its technology license with E3 Carbon, and deferred earthworks at its Kawerau project to Q3 2026, while maintaining a solid cash position.

Excite Technology Services has reported a record-breaking quarter with $9.2 million in customer receipts, marking a 125% increase year-over-year, alongside positive operating cash flow and strategic contract wins.

Fortescue Metals Group has delivered a record first half FY26 iron ore shipment of 100.2 million tonnes, alongside key progress in decarbonisation and strategic copper acquisition.

West Wits Mining has upsized its institutional placement to A$33.74 million, anchored by a $10 million strategic investment from Tribeca Investment Partners, fully funding the Qala Shallows project ahead of first gold pour in March 2026.

Cogstate Ltd has reported a remarkable 105% surge in clinical trial sales contracts for the first half of 2026, surpassing revenue guidance and signalling a more diversified and resilient business model.

Contact Energy's December 2025 report reveals stronger mass market sales and wholesale contracts alongside increased generation costs and ongoing renewable project developments.

Tivan Limited has made significant strides in its critical minerals portfolio, securing a $51.3 million strategic investment and progressing key feasibility studies across multiple projects.

Anteris Technologies has launched a $200 million public offering alongside a $90 million strategic investment from Medtronic, aiming to accelerate its DurAVR heart valve clinical trials and manufacturing expansion.

29Metals has announced a $150 million fully underwritten equity raising at a significant discount to support recovery from seismic disruptions at Xantho Extended and to advance key growth projects.

Qoria Limited has reported a record-breaking quarter with annual recurring revenue exceeding US$100 million and a 42% increase in net ARR for Q2 FY2026, reaffirming its strong growth trajectory and FY26 guidance.

Cambium Bio has locked in a A$2.4 million strategic investment from Zheng Yang Biomedical Technology, reinforcing its push into pivotal Phase 3 trials for its dry eye disease treatment.

Titan Minerals has reported outstanding infill drilling results at its Dynasty Gold Project, confirming wide, high-grade gold and silver mineralisation that bolsters resource confidence and supports an imminent resource estimate update.